Merial recognizing a decade of contributions to disease prevention and poultry production by VAXXITEK HVT+IBD

Merial
August 19, 2016
By Merial

August 19, 2016 - Merial is recognizing an important 10 year milestone of protecting flocks against Marek's disease and Gumboro disease (also known as Infectious Bursal Disease). Since the introduction of VAXXITEK HVT+IBD1 in Brazil in 2006, the vaccine has protected more than 70 billion birds across more than 75 countries against these two critical diseases, for which no treatment exists, considerably simplifying the vaccination process and contributing to disease prevention and efficiency strategies for poultry production businesses worldwide.

“We are extremely proud of the contributions of VAXXITEK HVT+IBD to poultry health in countries globally,” said Jérôme Baudon, Global Head of the Avian Business at Merial. It is one of the most used poultry vaccines in the world, and when it was introduced 10 years ago, Merial truly invented a new category by allowing for immunization against two diseases with a single vaccine dose given in the hatchery.”

Marek’s and Gumboro diseases are two of the most common, contagious and significant immunosuppressive viral diseases in poultry. In light of the growing need for protein in the world, innovative poultry health solutions, including VAXXITEK HVT+IBD, are critical to enhance poultry disease prevention, production and cost efficiencies. By 2020, chicken is expected to overtake pork as the global animal protein of choice.

“We started using VAXXITEK shortly after its launch and noted a big improvement in chick quality right from the start. Our customers reported fewer condemns and reduced mortality. Now we have customers asking for VAXXITEK-vaccinated chicks. We are extremely happy with the results,” said Ernie Silver, Hatchery Manager, Western Hatchery, Abbotsford, BC.

VAXXITEK HVT+IBD continues to represent a significant advance in vaccination, with only one single application for each bird. The vector-based vaccine is administered subcutaneously to one day old chicks or in-ovo (in the egg) in the hatchery. This approach enables continuity of protection against Marek’s Disease and IBD before chicks are placed on the farm, removing doubts about the right timing of vaccination, and also improving the consistency of quality vaccine delivery. In addition, VAXXITEK HVT+IBD provides excellent protection against a wide variety of IBD field strains without inducing bursa lesions or immunosuppression. For more product information, visit www.vaxxitek.com  

Add comment


Security code
Refresh

Subscription Centre

 
New Subscription
 
Already a Subscriber
 
Customer Service
 
View Digital Magazine Renew

Most Popular

Latest Events

No events

We are using cookies to give you the best experience on our website. By continuing to use the site, you agree to the use of cookies. To find out more, read our Privacy Policy.